Design of High-Specificity Nanocarriers by Exploiting Non-Equilibrium Effects in Cancer Cell Targeting

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapeutics

Background:

• Targeting cancer cells with drug-delivering nanocarriers aims to improve therapeutic specificity.
• Current strategies often focus on maximizing ligand affinity for overexpressed cancer cell receptors, which proves suboptimal.

Purpose of the Study:

• To determine design principles that maximize nanocarrier specificity for cancer cells.
• To investigate the role of system kinetics in nanocarrier-receptor interactions.

Main Methods:

• A generalized kinetics-based theoretical model was developed.
• The model studied nanocarriers with one or more ligands binding to overexpressed cancer cell receptors.

Main Results:

• System kinetics play a crucial role in determining nanocarrier specificity.
• Orders of magnitude improvement in specificity can be achieved by exploiting these kinetics.
• Specificity increases were observed with low rates of endocytosis and nanocarriers featuring multiple low-affinity ligands.

Conclusions:

• A paradigm shift is needed in receptor-targeted drug-delivery design.
• Optimal nanocarrier design involves low endocytosis rates and multiple low-affinity ligands.
• These findings are robust across various endocytosis mechanisms and drug-delivery protocols.